Clinical Trial Update: Phase I/II Trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHD [Phase 1, Phase 2]

View source ↗

Summary

This is a Phase I/II trial update for recombinant human keratinocyte growth factor (rHuKFG) aimed at treating steroid-refractory gastrointestinal acute graft-ve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• rHuKFG (recombinant human keratinocyte growth factor)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Graft Versus Host Disease | Phase 1, Phase 2 | Status: TERMINATED